Tirzepatide is more cost-effective than semaglutide for knee osteoarthritis and obesity, optimizing resources for patients ...

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs ...

Compared with usual care, the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) tirzepatide and semaglutide are cost-effective for people with knee osteoarthritis (OA) and obesity, according to a ...

Bariatric surgery increases 1-year acute kidney injury and 10-year nephrolithiasis risks but reduces chronic kidney disease and kidney failure risks compared with no surgery in a Danish registry study ...